{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:02:51Z","timestamp":1778137371786,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatic controlled attenuation parameter (CAP) is a novel marker for quantifying hepatic fat accumulation. Insulin resistance (IR) plays a major role in the pathogenesis and natural history of hepatic steatosis. This study aimed to investigate the possible relationship between CAP value and IR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included a total of 420 patients with overweight or obesity who came to the obesity clinic at Tianjin Union Medical Center. Vibration-controlled transient elastography examination was conducted to detect CAP and liver stiffness measurement (LSM) values. Body composition, including visceral fat area (VFA), and body fat mass (BFM), was evaluated by the direct segmental multi-frequency bioelectrical impedance analysis (BIA). The associations between CAP value, body mass index (BMI), VFA, BFM and homeostasis model assessment of insulin resistance (HOMA-IR) were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CAP value was positively associated with HOMA-IR (r\u2009=\u20090.568, P\u2009&lt;\u20090.001), the strength of which was much stronger than BMI, VFA, and BFM. In multivariate linear regression, CAP value and HOMA-IR showed a significant positive association (adjusted \u03b2\u2009=\u20090.015, 95% CI 0.007\u20130.022,<jats:italic> P<\/jats:italic>\u2009&lt;\u20090.001). Subgroup analysis suggested no significant interaction between CAP value and HOMA-IR across age, BMI, LSM, hypertension, and sex groups (all <jats:italic>P<\/jats:italic> for interaction\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Hepatic CAP value is more remarkably than other obesity markers associated with HOMA-IR in individuals with overweight or obesity, regardless of age, BMI, LSM, hypertension, and sex.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-024-01399-5","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:02:07Z","timestamp":1720504927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The correlation between hepatic controlled attenuation parameter (CAP) value and insulin resistance (IR) was stronger than that between body mass index, visceral fat area and IR"],"prefix":"10.1186","volume":"16","author":[{"given":"Zhouhuiling","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dangmin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxin","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"5","key":"1399_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288\u201398.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1399_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1399_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"X-F Pan","year":"2021","unstructured":"Pan X-F, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1399_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev. 2019;40(5):1367\u201393.","journal-title":"Endocr Rev"},{"key":"1399_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137: 111315.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1399_CR6","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"4","key":"1399_CR7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133\u2013223.","journal-title":"Physiol Rev"},{"key":"1399_CR8","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;2020:3920196.","journal-title":"J Diabetes Res"},{"issue":"3","key":"1399_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith GI, Shankaran M, Yoshino M, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest. 2020;130(3):1453\u201360.","journal-title":"J Clin Invest"},{"key":"1399_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12513","author":"C Bianco","year":"2023","unstructured":"Bianco C, Pelusi S, Margarita S, et al. Predictors of controlled attenuation parameter in metabolic dysfunction. United Eur Gastroenterol J. 2023. https:\/\/doi.org\/10.1002\/ueg2.12513.","journal-title":"United Eur Gastroenterol J"},{"issue":"11","key":"1399_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, De Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825\u201335.","journal-title":"Ultrasound Med Biol"},{"issue":"8","key":"1399_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/oby.23503","volume":"30","author":"A Gastaldelli","year":"2022","unstructured":"Gastaldelli A. Measuring and estimating insulin resistance in clinical and research settings. Obes Silver Spring Md. 2022;30(8):1549\u201363.","journal-title":"Obes Silver Spring Md"},{"key":"1399_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","author":"S Magali","year":"2010","unstructured":"Magali S, Michel B, de Victor L, et al. Controlled attenuation parameter (CAP): a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2010.07.005.","journal-title":"Ultrasound Med Biol"},{"key":"1399_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3902-y","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016. https:\/\/doi.org\/10.1007\/s00125-016-3902-y.","journal-title":"Diabetologia"},{"issue":"7","key":"1399_CR15","first-page":"1507","volume":"19","author":"K Koz\u0142owska-Petriczko","year":"2021","unstructured":"Koz\u0142owska-Petriczko K, Wunsch E, Milkiewicz P. Controlled attenuation parameter in nonalcoholic fatty liver disease: the thresholds do matter. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021;19(7):1507\u20138.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"6","key":"1399_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"11","key":"1399_CR17","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","volume":"19","author":"JG Stine","year":"2021","unstructured":"Stine JG, Munaganuru N, Barnard A, et al. Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(11):2274-2283.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1399_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13293-023-00549-0","volume":"14","author":"Y Wei","year":"2023","unstructured":"Wei Y, Liu J, Wang G, Wang Y. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults. Biol Sex Differ. 2023;14(1):69.","journal-title":"Biol Sex Differ"},{"issue":"13","key":"1399_CR19","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1073\/pnas.1922344117","volume":"117","author":"PK Luukkonen","year":"2020","unstructured":"Luukkonen PK, Dufour S, Lyu K, et al. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. Proc Natl Acad Sci. 2020;117(13):7347\u201354.","journal-title":"Proc Natl Acad Sci"},{"key":"1399_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101675","volume":"69","author":"F Long","year":"2023","unstructured":"Long F, Bhatti MR, Kellenberger A, et al. A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice. Mol Metab. 2023;69: 101675.","journal-title":"Mol Metab"},{"key":"1399_CR21","doi-asserted-by":"publisher","first-page":"1244405","DOI":"10.3389\/fendo.2023.1244405","volume":"14","author":"G Semmler","year":"2023","unstructured":"Semmler G, Balcar L, Wernly S, et al. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease. Front Endocrinol. 2023;14:1244405.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1399_CR22","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.gie.2020.08.023","volume":"93","author":"K Hajifathalian","year":"2021","unstructured":"Hajifathalian K, Mehta A, Ang B, et al. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. Gastrointest Endosc. 2021;93(5):1110\u20138.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1399_CR23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.28985","volume":"65","author":"F Bril","year":"2017","unstructured":"Bril F, Barb D, Portillo-Sanchez P, et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatol Baltim Md. 2017;65(4):1132\u201344.","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"1399_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2021.03.007","volume":"33","author":"GF Lewis","year":"2021","unstructured":"Lewis GF, Carpentier AC, Pereira S, Hahn M, Giacca A. Direct and indirect control of hepatic glucose production by insulin. Cell Metab. 2021;33(4):709\u201320.","journal-title":"Cell Metab"},{"issue":"4","key":"1399_CR25","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1016\/j.orcp.2013.08.002","volume":"8","author":"H Yatsuya","year":"2014","unstructured":"Yatsuya H, Nihashi T, Li Y, et al. Independent association of liver fat accumulation with insulin resistance. Obes Res Clin Pract. 2014;8(4):e350\u20135.","journal-title":"Obes Res Clin Pract"},{"key":"1399_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30084-1","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabet Endocrinol. 2019. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1.","journal-title":"Lancet Diabet Endocrinol"},{"issue":"7","key":"1399_CR27","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1210\/js.2019-00052","volume":"3","author":"S Kadowaki","year":"2019","unstructured":"Kadowaki S, Tamura Y, Someya Y, et al. Fatty liver has stronger association with insulin resistance than visceral fat accumulation in nonobese Japanese men. J Endocr Soc. 2019;3(7):1409\u201316.","journal-title":"J Endocr Soc"},{"issue":"9","key":"1399_CR28","first-page":"175","volume":"10","author":"N Urata","year":"2020","unstructured":"Urata N, Kawanaka M, Nishino K, et al. Fatty liver, and not visceral fat, is more associated with liver fibrosis and diabetes in non-obese Japanese individuals: a cross-sectional study. Life Basel Switz. 2020;10(9):175.","journal-title":"Life Basel Switz"},{"issue":"5","key":"1399_CR29","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/hep.30937","volume":"71","author":"B Dong","year":"2020","unstructured":"Dong B, Zhou Y, Wang W, et al. Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatol Baltim Md. 2020;71(5):1559\u201374.","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"1399_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","volume":"161","author":"A Fuchs","year":"2021","unstructured":"Fuchs A, Samovski D, Smith GI, et al. Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease. Gastroenterology. 2021;161(3):968-981.e12.","journal-title":"Gastroenterology"},{"issue":"3","key":"1399_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18(3):363\u201374.","journal-title":"Nat Med"},{"issue":"1","key":"1399_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1017\/S0029665119000569","volume":"79","author":"L Hodson","year":"2020","unstructured":"Hodson L, Rosqvist F, Parry SA. The influence of dietary fatty acids on liver fat content and metabolism. Proc Nutr Soc. 2020;79(1):30\u201341.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"1399_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-022-01299-y","volume":"8","author":"Z Fang","year":"2023","unstructured":"Fang Z, Xu H, Duan J, et al. Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK\/MAPK in mice. Signal Transduct Target Ther. 2023;8(1):94.","journal-title":"Signal Transduct Target Ther"},{"key":"1399_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.05.098","author":"A Mohammad","year":"2018","unstructured":"Mohammad A. Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG\/ PKC\/JNK pathway. Biomed Pharmacother. 2018. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.098.","journal-title":"Biomed Pharmacother"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-024-01399-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:07:25Z","timestamp":1720505245000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-024-01399-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1186\/s13098-024-01399-5","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Tianjin Union Medical Center (No. 2021C06). All participants provided informed consent before participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}